Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") annonce aujourd'hui la publication d'ILLUCCIX® (25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results